Dublin, Feb. 13, 2023 (GLOBE NEWSWIRE) -- The "Peptic Ulcer Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Peptic Ulcer Testing estimated at US$457.7 Million in the year 2022, is projected to reach a revised size of US$710.4 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2022-2030.
Laboratory Tests, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$372.2 Million by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Upper Endoscopy segment is readjusted to a revised 5.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $133.9 Million, While China is Forecast to Grow at 5.2% CAGR
The Peptic Ulcer Testing market in the U.S. is estimated at US$133.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$124.2 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 4.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.
Select Competitors (Total 41 Featured) -
- Beckman Coulter Inc.
- Becton Dickinson and Company
- Biohit Oyj
- Biomerica Inc.
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- DiaSorin S.p.A.
- EKF Diagnostics
- Exalenz Bioscience Ltd.
- Halyard Health Inc.
- Kibion AB
- Meridian Bioscience Inc.
- Orion Diagnostica Oy
- Otsuka America Pharmaceutical Inc.
- Quidel Corporation
- Sekisui Diagnostics LLC
- Thermo Fischer Scientific Inc.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Report Metrics:
| Report Attribute | Details |
| No. of Pages | 193 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $457.7 Million |
| Forecasted Market Value (USD) by 2030 | $710.4 Million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Peptic Ulcer Disease - A Global Phenomenon
- Recent Market Activity
- H. Pylori Infection: The Root Cause of Peptic Ulcer Disease
- Diagnosis of Peptic Ulcer Disease - Testing for H. Pylori Infection
- Market Outlook
- Developing Countries Lead Peptic Ulcer Testing Market
- Rising Incidence of Gastric Cancer: Potential Opportunities for H. Pylori Testing
- WHO Promotes H. Pylori Screening to Prevent Gastric Cancer-Related Deaths
- Competitive Scenario
- Select H. Pylori Diagnostic Tests/Test Kits Available in the Market
- A Review of Select H. Pylori Tests
- HeliprobeT Systems
- QuickVue H. pylori gII test
- CLOtest Rapid Urease Test
- EZ-H.P. (Bulk) and EZ-H.P. (Professional)
- BreathID Lab System
- Peptic Ulcer Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Sustained increase in Prevalence of Infectious Diseases Turns Focus onto Rapid Testing
- Higher Risk of H. pylori Disease Raises Demand for Testing from Elderly Population
- Differential Accuracy of Diagnostic Tests in Adults and Children
- Rapid Tests - Enabling Faster Testing for H. Pylori Infection
- Rapid Urease Tests: Most Useful Invasive Test for H. Pylori Detection
- Urea Breath Test - A Gold Standard in Non-Invasive Tests
- Availability of Tests Influences Market Adoption
- Cost Influencing Choice of Testing for H. Pylori
- Recommendations for H. Pylori Diagnostic Tests - An Overview
- Diagnostic Methods for H. Pylori Infection as Recommended by Guidelines in Select Countries
- Histology, UBT and SAT: Expensive Yet High-Value Offering Tests
- DVC-FISH Test Offers Positive Results in Detecting Viable H. Pylori Cells in Fecal Samples
- FIVH (fluorescence in vivo hybridization) - The New Kid on the Block
- Guidelines for Diagnosing H. Pylori Ulcers in Children
- Antibody Tests Not Recommended for Children; Biopsy Tests More Pertinent
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/ujoes1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
